Wyeth Receives Approvable Letter From FDA for Pristiq (Desvenlafaxine
WebWire - for Pristiq™ (desvenlafaxine succinate), a serotonin-norepinephrine reuptake inhibitor (SNRI) studied as a treatment The lifetime risk of major depression has been assessed from 10 to 25 percent for women and five to 12 percent for men
Source: www.webwire.com
Celexa relieves depression in heart patients
Reuters - NEW YORK (Reuters Health) - The antidepressant Celexa, known generically as citalopram, improves symptoms of major depression in doctors to "screen for depression in patients with coronary heart disease and maintain a low threshold for treatment with
Source: today.reuters.com
Landmark Govt. Study Examines Depression
First Coast News - The project started out with 3,671 adults diagnosed with major depression. Half of them had a family history of it, and more The rest switched to another antidepressant or continued with Celexa and added a second treatment. This second step
Source: www.firstcoastnews.com
Wyeth antidepressant’s real future could be in menopause market
Maryland Daily Record - A spokesperson for Wyeth said the company expects the Food and Drug Administration to tentatively approve Pristiq as a treatment for major depression, though the company will likely need to submit additional information to get the final OK. Wyeth
Source: www.mddailyrecord.com
Magnet Therapy
Belief.Net - A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biol Psychiatry. 2000;47:332–337. 26. Tergau F, Naumann U, Paulus W, et al. Low-frequency repetitive transcranial magnetic
Source: www.beliefnet.com
Click here for more information about depression forum depression forum
<< Home